Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.570
+0.110 (2.47%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $587.47 million as of April 28, 2026. Its market cap has increased by 23.62% in one year.
Market Cap
587.47M
Enterprise Value
349.69M
1-Year Change
23.62%
Ranking
Category
Stock Price
$4.57
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $587.47M, a decrease of -74.02%. That is a compound annual growth rate of -24.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 587.47M | -9.02% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CeriBell | 800.62M |
| BrainsWay | 663.54M |
| NeuroPace | 585.65M |
| SI-BONE | 581.80M |
| Tactile Systems Technology | 551.47M |
| Varex Imaging | 532.80M |
| Orthofix Medical | 494.58M |
| Perspective Therapeutics | 486.86M |